Panbela therapeutics, inc. closes acquisition of cancer prevention pharmaceuticals, inc.

Minneapolis, june 16, 2022 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, today announced the closing of its acquisition of cancer prevention pharmaceuticals, inc. (cpp), a private clinical stage company developing therapeutics to reduce the risk and recurrence of cancer and rare diseases, for a combination of stock and future milestone payments.
PBLA Ratings Summary
PBLA Quant Ranking